As reported here and elsewhere, a federal injunction banning federal funding for human embryonic stem cell research was overturned last Friday. For those of you interested in the legal details behind this development, Stanford law professor Hank Greely, JD, has written a lengthy and informative entry on the Law and Biosciences Blog. Greely’s conclusion?
April 29 was a good day for embryonic stem cell research. It has no immediate effect, as the injunction had been stayed, but it helps eliminate some of the legal uncertainty around this funding. It is not the end of the legal wrangling, but I think it greatly weakens the most serious legal challenge to this research.
Previously: Stem cell funding injunction overturned by federal court , Judge Lamberth’s stem cell opinion is disappointingly bad, More concern over US judge’s stem cell ruling and Stanford stem cell expert weighs in on district court ruling